Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
18.22B
Market cap18.22B
Price-Earnings ratio
26.24
Price-Earnings ratio26.24
Dividend yield
1.03%
Dividend yield1.03%
Average volume
1.94M
Average volume1.94M
High today
High today
Low today
Low today
Open price
$93.22
Open price$93.22
Volume
0.00
Volume0.00
52 Week high
$108.29
52 Week high$108.29
52 Week low
$84.59
52 Week low$84.59

Stock Snapshot

As of today, Zimmer Biomet(ZBH) shares are valued at $93.12. The company's market cap stands at 18.22B, with a P/E ratio of 26.24 and a dividend yield of 1.0%.

Zimmer Biomet(ZBH) stock opened on 2026-04-13 at $93.22. The price climbed to — and dipped to —.

The Zimmer Biomet(ZBH)'s current trading volume is 0, compared to an average daily volume of 1.94M.

During the past year, Zimmer Biomet(ZBH) stock moved between $84.59 at its lowest and $108.29 at its peak.

During the past year, Zimmer Biomet(ZBH) stock moved between $84.59 at its lowest and $108.29 at its peak.

ZBH News

TipRanks 45m
Zimmer Biomet initiated with a Market Perform at Leerink

Leerink initiated coverage of Zimmer Biomet (ZBH) with a Market Perform rating and $10 price target While the shares are trading at a discount to its large-cap...

Simply Wall St 8h
The Bull Case For Zimmer Biomet Could Change Following First Outpatient Robotic Shoulder Replacement

In early April 2026, Summit Health announced that orthopedic surgeon Eric Black, MD, used Zimmer Biomet’s ROSA Robotics Platform to perform the nation’s first c...

The Bull Case For Zimmer Biomet Could Change Following First Outpatient Robotic Shoulder Replacement
Simply Wall St 3d
The Tactical Trio: One AI Imaging Blueprint, One Orthopedic Value Play, One Surgical Compounder

Artificial intelligence in healthcare is attracting fresh attention as investors weigh higher for longer inflation risks, volatile bond yields, and energy drive...

The Tactical Trio: One AI Imaging Blueprint, One Orthopedic Value Play, One Surgical Compounder

Analyst ratings

60%

of 30 ratings
Buy
30%
Hold
60%
Sell
10%

More ZBH News

Simply Wall St 5d
Zimmer Biomet Valuation Check After Mixed Returns And Robotics Growth Plans

Zimmer Biomet Holdings (ZBH) has drawn investor attention after recent trading left the stock with mixed returns, including a loss over the past year despite mo...

Zimmer Biomet Valuation Check After Mixed Returns And Robotics Growth Plans
TipRanks 6d
Zimmer Biomet names new Chief Science, Technology and Medical Affairs Officer

Zimmer Biomet (ZBH) appointed Jonathan Vigdorchik as Chief Science, Technology and Medical Affairs Officer, effective April 14. In this role, Vigdorchik will ov...

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.